Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)
Bicycle Therapeutics (BCYC) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.09 as the latest value for Q1 2026.
- For Q1 2026, Asset Utilization Ratio rose 231.68% year-over-year to 0.09; the TTM value through Mar 2026 reached 0.09, up 231.68%, while the annual FY2025 figure was 0.09, 90.75% up from the prior year.
- Asset Utilization Ratio hit 0.09 in Q1 2026 for Bicycle Therapeutics, down from 0.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.1 in Q4 2025 and bottomed at 0.02 in Q2 2025.
- Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.04 recorded in 2022.
- Year-over-year, Asset Utilization Ratio crashed 57.13% in 2022 and then surged 266.09% in 2025.
- Bicycle Therapeutics' Asset Utilization Ratio stood at 0.06 in 2022, then decreased by 23.65% to 0.04 in 2023, then plummeted by 38.78% to 0.03 in 2024, then soared by 266.09% to 0.1 in 2025, then dropped by 5.4% to 0.09 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.09, 0.1, and 0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.